Cytomx Therapeutics Stock Price Patterns
| CTMX Stock | USD 5.47 0.06 1.11% |
Momentum 60
Buy Extended
Oversold | Overbought |
Quarterly Earnings Growth 0.606 | EPS Estimate Next Quarter (0.05) | EPS Estimate Current Year (0.02) | EPS Estimate Next Year (0.37) | Wall Street Target Price 9 |
Using CytomX Therapeutics hype-based prediction, you can estimate the value of CytomX Therapeutics from the perspective of CytomX Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards CytomX Therapeutics using CytomX Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards CytomX using crowd psychology based on the activity and movement of CytomX Therapeutics' stock price.
CytomX Therapeutics Short Interest
An investor who is long CytomX Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about CytomX Therapeutics and may potentially protect profits, hedge CytomX Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 3.1479 | Short Percent 0.0906 | Short Ratio 4.71 | Shares Short Prior Month 16.1 M | 50 Day MA 4.7324 |
CytomX Therapeutics Hype to Price Pattern
Investor biases related to CytomX Therapeutics' public news can be used to forecast risks associated with an investment in CytomX. The trend in average sentiment can be used to explain how an investor holding CytomX can time the market purely based on public headlines and social activities around CytomX Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of CytomX Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about CytomX Therapeutics.
CytomX Therapeutics Implied Volatility | 2.08 |
CytomX Therapeutics' implied volatility exposes the market's sentiment of CytomX Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if CytomX Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that CytomX Therapeutics stock will not fluctuate a lot when CytomX Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in CytomX Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying CytomX because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CytomX Therapeutics after-hype prediction price | USD 5.9 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current CytomX contract
Based on the Rule 16, the options market is currently suggesting that CytomX Therapeutics will have an average daily up or down price movement of about 0.13% per day over the life of the 2026-05-15 option contract. With CytomX Therapeutics trading at USD 5.47, that is roughly USD 0.007111 . If you think that the market is fully incorporating CytomX Therapeutics' daily price movement you should consider acquiring CytomX Therapeutics options at the current volatility level of 2.08%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out CytomX Therapeutics Basic Forecasting Models to cross-verify your projections. CytomX Therapeutics After-Hype Price Density Analysis
As far as predicting the price of CytomX Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CytomX Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of CytomX Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CytomX Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting CytomX Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CytomX Therapeutics' historical news coverage. CytomX Therapeutics' after-hype downside and upside margins for the prediction period are 0.65 and 11.15, respectively. We have considered CytomX Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CytomX Therapeutics is relatively risky at this time. Analysis and calculation of next after-hype price of CytomX Therapeutics is based on 3 months time horizon.
CytomX Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as CytomX Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CytomX Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CytomX Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.70 | 5.21 | 0.44 | 0.11 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
5.47 | 5.90 | 7.86 |
|
CytomX Therapeutics Hype Timeline
CytomX Therapeutics is currently traded for 5.47. The entity has historical hype elasticity of 0.44, and average elasticity to hype of competition of -0.11. CytomX is expected to increase in value after the next headline, with the price projected to jump to 5.9 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 7.86%, whereas the daily expected return is currently at 0.7%. The volatility of related hype on CytomX Therapeutics is about 3276.73%, with the expected price after the next announcement by competition of 5.36. The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (2.64) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.64. Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out CytomX Therapeutics Basic Forecasting Models to cross-verify your projections.CytomX Therapeutics Related Hype Analysis
Having access to credible news sources related to CytomX Therapeutics' direct competition is more important than ever and may enhance your ability to predict CytomX Therapeutics' future price movements. Getting to know how CytomX Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CytomX Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ERAS | Erasca Inc | 0.16 | 9 per month | 2.47 | 0.35 | 15.04 | (4.72) | 50.26 | |
| IOVA | Iovance Biotherapeutics | 0.12 | 8 per month | 4.13 | 0.01 | 9.47 | (7.58) | 21.32 | |
| MBX | MBX Biosciences Common | (1.91) | 7 per month | 4.04 | 0.15 | 14.40 | (7.47) | 29.11 | |
| AVBP | ArriVent BioPharma Common | 0.35 | 3 per month | 2.92 | 0.06 | 6.71 | (4.81) | 18.12 | |
| MGTX | MeiraGTx Holdings PLC | (0.36) | 8 per month | 0.00 | (0.06) | 5.08 | (5.54) | 16.37 | |
| ATXS | Astria Therapeutics | 0.05 | 7 per month | 1.00 | 0.03 | 2.11 | (1.67) | 6.54 | |
| MLTX | MoonLake Immunotherapeutics | 0.37 | 10 per month | 3.74 | 0.11 | 11.10 | (6.36) | 35.46 | |
| REPL | Replimune Group | 0.14 | 8 per month | 0.00 | (0.04) | 5.73 | (5.39) | 20.74 | |
| DNA | Ginkgo Bioworks Holdings | (0.42) | 9 per month | 4.16 | 0.03 | 8.31 | (6.36) | 30.46 | |
| AVXL | Anavex Life Sciences | (0.09) | 7 per month | 0.00 | (0.08) | 8.16 | (8.97) | 35.85 |
CytomX Therapeutics Additional Predictive Modules
Most predictive techniques to examine CytomX price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CytomX using various technical indicators. When you analyze CytomX charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CytomX Therapeutics Predictive Indicators
The successful prediction of CytomX Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CytomX Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CytomX Therapeutics based on analysis of CytomX Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CytomX Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CytomX Therapeutics's related companies. | 2025 | 2026 (projected) | Dividend Yield | 0.00815 | 0.007244 | Price To Sales Ratio | 0.72 | 0.69 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for CytomX Stock Analysis
When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.